Skip to main content
Fig. 4 | BMC Pulmonary Medicine

Fig. 4

From: Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients

Fig. 4

Dynamic monitoring of dd-cfDNA assisted LTRs treatment for decreased lung function. A Dynamics of dd-cfDNA before and after the treatment for LTRs, the black dot represents the results of two dd-cfDNA tests pre-treatment (Pre-T) and post-treatment (Post-T). B dd-cfDNA (%) and pathological monitoring of an ACR patient during treatment, the black dots represent the results of four dd-cfDNA tests during the treatment, and the arrows indicate the time point when AR was diagnosed and anti-rejection treatment was performed

Back to article page